Liu Jin, Matsuo Hiroya, Laoag-Fernandez Jovelle B, Xu Qin, Maruo Takeshi
Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe 650-0017, Japan.
Mol Hum Reprod. 2007 Dec;13(12):869-74. doi: 10.1093/molehr/gam078. Epub 2007 Oct 25.
Progesterone (P4) is frequently used in the treatment of threatened abortion, prevention of recurrent miscarriage and threatened preterm labor. However, little is known about the molecular mechanism of P4 in the regulation of extravillous trophoblasts' (EVTs) function. This study was designed to examine the presence of progesterone receptor (PR) in the human trophoblast-derived HTR-8/SV neo cell line, which is a possible model of EVTs, and the effects of P4 on apoptosis in those cells. The HTR-8/SV neo cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 microg/ml streptomycin. When the cell the population reached 50% confluency, the cells were stepped down to serum-free conditions in the presence or absence of graded concentrations of P4 (1, 10 and 100 ng/ml) for 48 h. The cultured cells were used for RT-PCR, terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick end labeling (TUNEL) assay, immunocytochemistry and western blot analyses. Immunocytochemistry and western blot analyses revealed that PR was evident in HTR-8/SV neo cells. Compared with untreated cultures, treatment with P4 (10 and 100 ng/ml) resulted in significant decreases in the TUNEL-positive rate, Fas, Fas ligand (Fas-L), caspase-8, caspase-3 and poly (ADP-ribose) polymerase (PARP) expression in HTR-8/SV neo cells, and a significant increase in Bcl-2 expression in those cells. Consistently, Fas mRNA expression in those cells was significantly inhibited by the treatment with 10 ng/ml P4 compared with untreated cultures. This study suggests that PR exists in HTR-8/SV neo cells and that P4 inhibits apoptosis by down-regulating Fas, Fas-L, caspase-8, caspase-3 and PARP expression as well as up-regulating Bcl-2 expression in HTR-8/SV neo cells.
孕酮(P4)常用于治疗先兆流产、预防复发性流产和先兆早产。然而,关于P4调节绒毛外滋养层细胞(EVTs)功能的分子机制知之甚少。本研究旨在检测人滋养层来源的HTR-8/SV neo细胞系(一种可能的EVTs模型)中孕酮受体(PR)的存在情况,以及P4对这些细胞凋亡的影响。将HTR-8/SV neo细胞培养于添加有10%胎牛血清、100 U/ml青霉素和100 μg/ml链霉素的RPMI 1640培养基中。当细胞达到50%汇合度时,在有或无梯度浓度P4(1、10和100 ng/ml)的情况下,将细胞转入无血清条件培养48小时。将培养的细胞用于逆转录聚合酶链反应(RT-PCR)、末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)检测、免疫细胞化学和蛋白质印迹分析。免疫细胞化学和蛋白质印迹分析显示,PR在HTR-8/SV neo细胞中明显存在。与未处理的培养物相比,用P4(10和100 ng/ml)处理导致HTR-8/SV neo细胞中TUNEL阳性率、Fas、Fas配体(Fas-L)、半胱天冬酶-8、半胱天冬酶-3和聚(ADP-核糖)聚合酶(PARP)表达显著降低,而这些细胞中Bcl-2表达显著增加。同样,与未处理的培养物相比,用10 ng/ml P4处理可显著抑制这些细胞中Fas mRNA表达。本研究表明,PR存在于HTR-8/SV neo细胞中,且P4通过下调HTR-8/SV neo细胞中Fas、Fas-L、半胱天冬酶-8、半胱天冬酶-3和PARP表达以及上调Bcl-2表达来抑制细胞凋亡。